This has not been described before in prediabetes or T2D and may indicate that in parallel with the modification of the long-chain lysoPCs there is also a disturbed regulation of very-long-chain PCs in risk subjects carrying the TCF7L2 risk allele. The gene discussed is TCF7L2; the disease is prediabetes syndrome.